Search

Joshua Joo

Examiner (ID: 11954, Phone: (571)272-3966 , Office: P/2445 )

Most Active Art Unit
2445
Art Unit(s)
2154, 2454, 2445
Total Applications
1186
Issued Applications
850
Pending Applications
94
Abandoned Applications
264

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6939813 [patent_doc_number] => 20050113376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Compositions of a cyclooxygenase-2 selective inhibitor, a xanthine compound and an alcohol for the treatment of ischemic mediated central nervous system disorders or injury' [patent_app_type] => utility [patent_app_number] => 10/854648 [patent_app_country] => US [patent_app_date] => 2004-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25077 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20050113376.pdf [firstpage_image] =>[orig_patent_app_number] => 10854648 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/854648
Compositions of a cyclooxygenase-2 selective inhibitor, a xanthine compound and an alcohol for the treatment of ischemic mediated central nervous system disorders or injury May 25, 2004 Abandoned
Array ( [id] => 843732 [patent_doc_number] => 07388030 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-17 [patent_title] => 'Suppressors of anemia and appetite suppressors and methods for suppressing anemia and suppressing appetite' [patent_app_type] => utility [patent_app_number] => 10/851338 [patent_app_country] => US [patent_app_date] => 2004-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 8029 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/388/07388030.pdf [firstpage_image] =>[orig_patent_app_number] => 10851338 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/851338
Suppressors of anemia and appetite suppressors and methods for suppressing anemia and suppressing appetite May 23, 2004 Issued
Array ( [id] => 7089780 [patent_doc_number] => 20050009893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Treatment of high blood pressure during the acute phase of a stroke' [patent_app_type] => utility [patent_app_number] => 10/851660 [patent_app_country] => US [patent_app_date] => 2004-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1394 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009893.pdf [firstpage_image] =>[orig_patent_app_number] => 10851660 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/851660
Treatment of high blood pressure during the acute phase of a stroke May 23, 2004 Abandoned
Array ( [id] => 7378407 [patent_doc_number] => 20040220188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Alkylidene pyrazolidinedione derivatives' [patent_app_type] => new [patent_app_number] => 10/481240 [patent_app_country] => US [patent_app_date] => 2004-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26204 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220188.pdf [firstpage_image] =>[orig_patent_app_number] => 10481240 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/481240
Alkylidene pyrazolidinedione derivatives May 20, 2004 Abandoned
Array ( [id] => 7378368 [patent_doc_number] => 20040220184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD)' [patent_app_type] => new [patent_app_number] => 10/851826 [patent_app_country] => US [patent_app_date] => 2004-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11121 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220184.pdf [firstpage_image] =>[orig_patent_app_number] => 10851826 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/851826
Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD) May 20, 2004 Abandoned
Array ( [id] => 7297517 [patent_doc_number] => 20040214845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Barbiturates as integrin antagonists and their use for treating inflammatory diseases' [patent_app_type] => new [patent_app_number] => 10/848718 [patent_app_country] => US [patent_app_date] => 2004-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6057 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214845.pdf [firstpage_image] =>[orig_patent_app_number] => 10848718 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/848718
Barbiturates as integrin antagonists and their use for treating inflammatory diseases May 18, 2004 Abandoned
Array ( [id] => 6939870 [patent_doc_number] => 20050113433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Compositions of a phenyl acetic acid cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous system' [patent_app_type] => utility [patent_app_number] => 10/845009 [patent_app_country] => US [patent_app_date] => 2004-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15041 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20050113433.pdf [firstpage_image] =>[orig_patent_app_number] => 10845009 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/845009
Compositions of a phenyl acetic acid cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous system May 12, 2004 Abandoned
Array ( [id] => 435962 [patent_doc_number] => 07262219 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-28 [patent_title] => 'Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy' [patent_app_type] => utility [patent_app_number] => 10/841709 [patent_app_country] => US [patent_app_date] => 2004-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 28657 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/262/07262219.pdf [firstpage_image] =>[orig_patent_app_number] => 10841709 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/841709
Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy May 6, 2004 Issued
Array ( [id] => 7434448 [patent_doc_number] => 20040209952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Composition containing chalcone' [patent_app_type] => new [patent_app_number] => 10/838853 [patent_app_country] => US [patent_app_date] => 2004-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6137 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20040209952.pdf [firstpage_image] =>[orig_patent_app_number] => 10838853 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/838853
Composition containing chalcone May 2, 2004 Issued
Array ( [id] => 577975 [patent_doc_number] => 07456179 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-25 [patent_title] => 'Methods of treating ischemic related conditions' [patent_app_type] => utility [patent_app_number] => 10/835668 [patent_app_country] => US [patent_app_date] => 2004-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11898 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/456/07456179.pdf [firstpage_image] =>[orig_patent_app_number] => 10835668 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/835668
Methods of treating ischemic related conditions Apr 29, 2004 Issued
Array ( [id] => 7352068 [patent_doc_number] => 20040248928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Pharmaceutical composition comprising an adenosine A1/A2 agonist and a sodium hydrogen exchanger inhibitor' [patent_app_type] => new [patent_app_number] => 10/835964 [patent_app_country] => US [patent_app_date] => 2004-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8012 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248928.pdf [firstpage_image] =>[orig_patent_app_number] => 10835964 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/835964
Pharmaceutical composition comprising an adenosine A1/A2 agonist and a sodium hydrogen exchanger inhibitor Apr 29, 2004 Abandoned
Array ( [id] => 7330095 [patent_doc_number] => 20040254208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Compositions for affecting weight loss' [patent_app_type] => new [patent_app_number] => 10/828795 [patent_app_country] => US [patent_app_date] => 2004-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14960 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20040254208.pdf [firstpage_image] =>[orig_patent_app_number] => 10828795 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/828795
Compositions for affecting weight loss Apr 20, 2004 Issued
Array ( [id] => 7466830 [patent_doc_number] => 20040198771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation' [patent_app_type] => new [patent_app_number] => 10/823862 [patent_app_country] => US [patent_app_date] => 2004-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16614 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198771.pdf [firstpage_image] =>[orig_patent_app_number] => 10823862 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/823862
Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation Apr 13, 2004 Issued
Array ( [id] => 4675584 [patent_doc_number] => 20080213213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Method For the Treatment of Myelodysplastic Syndromes Using (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione' [patent_app_type] => utility [patent_app_number] => 11/547927 [patent_app_country] => US [patent_app_date] => 2004-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24271 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213213.pdf [firstpage_image] =>[orig_patent_app_number] => 11547927 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/547927
Method For the Treatment of Myelodysplastic Syndromes Using (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione Apr 13, 2004 Abandoned
Array ( [id] => 7127912 [patent_doc_number] => 20050059656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Compositions and methods for protecting against mitochondria component-mediated pathology' [patent_app_type] => utility [patent_app_number] => 10/820184 [patent_app_country] => US [patent_app_date] => 2004-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 280 [patent_figures_cnt] => 280 [patent_no_of_words] => 9961 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059656.pdf [firstpage_image] =>[orig_patent_app_number] => 10820184 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/820184
Compositions and methods for protecting against mitochondria component-mediated pathology Apr 6, 2004 Abandoned
Array ( [id] => 7672936 [patent_doc_number] => 20040180843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Treatment of helicobacter with isothocyanates' [patent_app_type] => new [patent_app_number] => 10/813015 [patent_app_country] => US [patent_app_date] => 2004-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7780 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180843.pdf [firstpage_image] =>[orig_patent_app_number] => 10813015 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/813015
Treatment of Helicobacter with isothiocyanates Mar 30, 2004 Issued
Array ( [id] => 7018843 [patent_doc_number] => 20050220862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Compositions with reduced hepatotoxicity' [patent_app_type] => utility [patent_app_number] => 10/813760 [patent_app_country] => US [patent_app_date] => 2004-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1708 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20050220862.pdf [firstpage_image] =>[orig_patent_app_number] => 10813760 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/813760
Compositions with reduced hepatotoxicity Mar 30, 2004 Abandoned
Array ( [id] => 7347622 [patent_doc_number] => 20040192773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Preventive or remedy for hypertension' [patent_app_type] => new [patent_app_number] => 10/810611 [patent_app_country] => US [patent_app_date] => 2004-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4680 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20040192773.pdf [firstpage_image] =>[orig_patent_app_number] => 10810611 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/810611
Preventive or remedy for hypertension Mar 28, 2004 Issued
Array ( [id] => 7672816 [patent_doc_number] => 20040180963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease' [patent_app_type] => new [patent_app_number] => 10/810682 [patent_app_country] => US [patent_app_date] => 2004-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4167 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180963.pdf [firstpage_image] =>[orig_patent_app_number] => 10810682 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/810682
Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease Mar 28, 2004 Abandoned
Array ( [id] => 7351399 [patent_doc_number] => 20040248825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Use of neuraminidase inhibitors to prevent flu associated bacterial infections' [patent_app_type] => new [patent_app_number] => 10/809127 [patent_app_country] => US [patent_app_date] => 2004-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10450 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248825.pdf [firstpage_image] =>[orig_patent_app_number] => 10809127 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/809127
Use of neuraminidase inhibitors to prevent flu associated bacterial infections Mar 24, 2004 Abandoned
Menu